Last reviewed · How we verify
NCT04929964: COVID-19
COVID-19 Pandemic: Effect on Management of Patients With Breast Cancer
trial testing MRM , Toilet Mastectomy , BCS in Covid19 in 87 participants. Completed in 31 January 2021.
31 January 2021
Quick facts
| Lead sponsor | Mehwish Mooghal , MBBS |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 87 |
| Start date | 1 January 2020 |
| Primary completion | 31 January 2021 |
| Estimated completion | 31 January 2021 |
| Sites | 1 location across Pakistan |
Drugs / interventions tested
- MRM , Toilet Mastectomy , BCS
Conditions studied
- Covid19 — all drugs for Covid19 →
- Breast Cancer Stage — all drugs for Breast Cancer Stage →
- Isolation, Social — all drugs for Isolation, Social →
- Locally Advanced Breast Cancer — all drugs for Locally Advanced Breast Cancer →
Sponsor
Mehwish Mooghal , MBBS
Who can join
Adults 25 to 71, female only, with Covid19 or Breast Cancer Stage. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objective was to find out the impact of COVID-19 on stage of breast cancer at presentation and its effects on overall onco-surgical management. The investigator carried out this research to see the presenting stage of breast cancer in the participants in this pandemic and correlate its effect on stage of breast cancer and upstaging of disease
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
COVID 19 pandemic: Effect on management of patients with breast cancer; single center retrospective cohort study.
Mooghal M, Javaid RH, Khan W, Muneeb M, et al · · 2021 · cited 4× · PMID 34568622 · DOI 10.1016/j.ijso.2021.100386 -
Microorganisms and Breast Cancer: An In-Depth Analysis of Clinical Studies.
Naderi N, Mosahebi A, Williams NR. · · 2023 · cited 2× · PMID 38276152 · DOI 10.3390/pathogens13010006
Verify or expand the search:
- PubMed search for NCT04929964
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Covid19
Currently open trials in the same condition.
- NCT03305341 — Proof-of-Concept Clinical Pharmacology Trial for COVID-19 Antigen Presentation Therapeutic Biologic Mix · EARLY_PHASE1 · active not recruiting
- NCT06482138 — Dysfunction of Olfaction After COVID-19 Infection: Morphological and Histomolecular Investigation · NA · recruiting
- NCT04924803 — Community Developed Technology-Based Messaging to Increase COVID-19 Vaccine Uptake Among People Who Inject Drugs · NA · active not recruiting
- NCT05013632 — COVID-19 International Drug Pregnancy Registry · recruiting
- NCT04806061 — Urine Alkalinisation in COVID-19 · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04929964 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Mehwish Mooghal , MBBS
- Last refreshed: 11 August 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04929964.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing